2018
$49M
from 4 investors over 4 rounds
HDT Bio raised $49M on November 30, 2022
Investors: Medical CBRN Defense Consortium
HDT Bio raised $2.9M on May 17, 2021
Investors: National Institutes of Health
HDT Bio raised $4M on October 5, 2020
Investors: Zoic Capital
HDT Bio raised $8.3M on September 1, 2020
Investors: National Institute of Allergy and Infectious Diseases (NIAID)